Results 61 to 70 of about 2,823 (143)

Biocide Response of Candida auris

open access: yesMycoses, Volume 69, Issue 3, March 2026.
ABSTRACT Candida auris is an emerging multidrug‐resistant yeast demonstrating remarkable persistence in healthcare environments, contributing to nosocomial transmission and outbreak persistence. Increasing disinfectant failure reports have raised concerns regarding infection control policies, as environmental reservoirs play central roles in its spread.
Sidre Erganis   +3 more
wiley   +1 more source

Emergence of Candida (Candidozyma) auris in Minas Gerais, Brazil: Genomic Surveillance to Guide Rapid Public Health Responses

open access: yesMycoses, Volume 69, Issue 2, February 2026.
ABSTRACT Background Candida (Candidozyma) auris is an emerging yeast that poses a significant global health threat due to its multidrug resistance and ability to cause healthcare‐associated outbreaks. Genomic surveillance is essential for monitoring spread, transmission and antifungal resistance.
Luiz Marcelo Ribeiro Tomé   +19 more
wiley   +1 more source

Characterization of the chitin biosynthesis process as a compensatory mechanism in the fks1 mutant of Saccharomyces cerevisiae [PDF]

open access: yes, 2000
Deletion of the 1,3-β-D-glucan synthase gene FKS1 in Saccharomyces cerevisiae induces a compensatory mechanism that is reflected in a significant increase in chitin synthase III (CSIII) activity, leading to high rates of chitin synthesis. Deregulation of
Castro, C   +11 more
core   +1 more source

Monitoring the Diversity and Antifungal Susceptibility of Candida Isolates at Adam Malik Hospital, Medan, Indonesia

open access: yesInternational Journal of Microbiology, Volume 2026, Issue 1, 2026.
Candida species are well‐known for their capacity to cause a broad range of infections in humans. Invasive and device‐related infections caused by Candida albicans and non‐albicans contribute to a relatively high mortality rate, thereby becoming a major public health concern around the world.
Evita Mayasari   +2 more
wiley   +1 more source

First Report of Human Infection Caused by Aspergillus steynii and Analysis of Its Whole‐Genome Characteristics

open access: yesTransboundary and Emerging Diseases, Volume 2026, Issue 1, 2026.
The incidence of infections caused by rare pathogens has increased in recent years. This necessitates the development of effective diagnostic and therapeutic approaches. In this study, we report the first documented case of Aspergillus steynii‐induced pulmonary infection in humans.
Ruixuan Wang   +12 more
wiley   +1 more source

Acquired echinocandin resistance in a Candida krusei blood isolate confirmed by mutations in the fks1 gene

open access: yes, 2014
We describe a case of bloodstream infection caused by a Candida krusei strain that developed echinocandin resistance during caspofungin therapy. Three mutations were found in the HS1 region of the fks1 gene, two of them have never been reported either in
A.M. Tortorano   +5 more
core   +2 more sources

Yeast species-specific, differential inhibition of β-1,3-glucan synthesis by poacic acid and caspofungin

open access: yesThe Cell Surface, 2018
The rise of widespread antifungal resistance fuels the need to explore new classes of inhibitory molecules as potential novel inhibitors. Recently a plant natural product poacic acid (PA) was shown to inhibit β-1,3-glucan synthesis, and to have ...
Keunsook K. Lee   +8 more
doaj   +1 more source

Structural, Mechanical, and Genetic Insights into Heat‐Pressed Fomes Fomentarius Mycelium from Solid‐State and Liquid Cultivations

open access: yesAdvanced Sustainable Systems, Volume 9, Issue 10, October 2025.
Fungal mycelium‐based materials are an upcoming class of sustainable materials. Heat ‐pressing is a promising post‐processing technique to produce fungal mycelium‐based particle boards or leather substitutes. However, little is known about the mechanism involved.
Huaiyou Chen   +9 more
wiley   +1 more source

Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-d-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus

open access: yesmBio, 2019
Aspergillus fumigatus is a leading cause of invasive fungal infections. Resistance to first-line triazole antifungals has led to therapy with echinocandin drugs. Recently, we identified several high-minimum-effective-concentration (MEC) A.
Shruthi Satish   +10 more
doaj   +1 more source

Repositioning Antimicrobial Peptides Against WHO‐Priority Fungi

open access: yesAdvanced Science, Volume 12, Issue 37, October 6, 2025.
The growing burden of drug‐resistant fungal infections, driven by pathogens such as Candida auris, Cryptococcus neoformans, and Aspergillus fumigatus, underscores the urgent need for novel antifungal therapies. This review explores antimicrobial peptides as promising agents with membrane‐disruptive activity, immunomodulatory properties, and delivery ...
Cesar Augusto Roque‐Borda   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy